AUG 10, 2026 · JOURNAL ARTICLE
Tirzepatide Use Is Associated with Reduced Risk of Carpal Tunnel Syndrome in Overweight and Obese Adults
Clinical Pharmacology & Therapeutics
Retrospective cohort study with propensity score matching showing reduced CTS risk with tirzepatide versus comparators, but observational design, potential residual confounding, and surrogate clinical outcomes limit strength.
Reported
Hazard ratio (tirzepatide vs GLP-…0.82
95% CI (tirzepatide vs GLP-1RA) f…0.71–0.95
Hazard ratio (tirzepatide vs othe…0.75